首页 > 最新文献

Acta Anaesthesiologica Scandinavica最新文献

英文 中文
Clinical leadership education-A scoping review protocol. 临床领导教育-范围审查方案。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.14591
Naja Vaaben, Peter Dieckmann, Ann Merete Møller

Introduction: Leadership is a key skill for physicians, but studies show that many junior doctors feel unprepared for the role as a leader. In recent years, there has been increasing interest and research into the training and development of clinical leadership, revolving around leadership in situations with direct patient care and as opposed to the administrative leadership of a department. However, the lack of consensus on how best to teach leadership, how the education should be structured, as well as a standardized definition and measure for good leadership, complicates training, assessment, and comparison of approaches in both research and education.

Objective: The aim of this study is to map out the existing body of research on leadership education for physicians and medical students and identify any gaps in this literature.

Methods: The scoping review will follow the Arksey and O'Malley (Arksey and O'Malley, Int J Soc Res Methodol. 2005; 8(1):19-32) framework, Joanna Briggs Institute methodology (JBI Manual for Evidence Synthesis-JBI Global Wiki) and PRISMA_ScR (Tricco et al., Ann Intern Med. 2018; 169(7):467-473). A systematic search will be conducted across the following databases: PubMed, Cochrane, Embase, Ebsco, Medline, and Google scholar. Two independent reviewers will screen titles and abstracts, then review the full texts of articles. Data will be extracted and presented in line with the review questions.

Strengths and limitations of this study: The study will use a structured approach, as guided by Arksey and O'Malley and JBI methodology. Studies not written in English, Danish, German, Swedish, and Norwegian will be translated using available software. This review will not include a formal assessment of the study quality or meta-analysis, as it is a scoping review.

导言:领导力是医生的一项关键技能,但研究表明,许多初级医生认为自己还没有做好担任领导者的准备。近年来,人们对临床领导力的培训和发展越来越感兴趣,并开展了越来越多的研究,这些研究围绕着在直接照顾病人的情况下的领导力,而不是一个部门的行政领导力。然而,在如何最好地教授领导力、如何构建教育结构以及良好领导力的标准化定义和衡量标准方面缺乏共识,这使得培训、评估以及研究和教育方法的比较变得复杂:本研究的目的是对医生和医学生领导力教育的现有研究进行梳理,并找出文献中的空白点:方法:范围界定审查将遵循Arksey和O'Malley(Arksey和O'Malley,Int J Soc Res Methodol.2005;8(1):19-32)框架、乔安娜-布里格斯研究所方法学(JBI Manual for Evidence Synthesis-JBI Global Wiki)和PRISMA_ScR(Tricco et al.2018; 169(7):467-473).将在以下数据库中进行系统检索:PubMed、Cochrane、Embase、Ebsco、Medline 和 Google scholar。两名独立审稿人将筛选标题和摘要,然后审阅文章全文。本研究的优势和局限:本研究将采用 Arksey 和 O'Malley 以及 JBI 方法指导下的结构化方法。非英语、丹麦语、德语、瑞典语和挪威语撰写的研究报告将使用现有软件进行翻译。本综述不包括对研究质量的正式评估或荟萃分析,因为它只是范围界定综述。
{"title":"Clinical leadership education-A scoping review protocol.","authors":"Naja Vaaben, Peter Dieckmann, Ann Merete Møller","doi":"10.1111/aas.14591","DOIUrl":"10.1111/aas.14591","url":null,"abstract":"<p><strong>Introduction: </strong>Leadership is a key skill for physicians, but studies show that many junior doctors feel unprepared for the role as a leader. In recent years, there has been increasing interest and research into the training and development of clinical leadership, revolving around leadership in situations with direct patient care and as opposed to the administrative leadership of a department. However, the lack of consensus on how best to teach leadership, how the education should be structured, as well as a standardized definition and measure for good leadership, complicates training, assessment, and comparison of approaches in both research and education.</p><p><strong>Objective: </strong>The aim of this study is to map out the existing body of research on leadership education for physicians and medical students and identify any gaps in this literature.</p><p><strong>Methods: </strong>The scoping review will follow the Arksey and O'Malley (Arksey and O'Malley, Int J Soc Res Methodol. 2005; 8(1):19-32) framework, Joanna Briggs Institute methodology (JBI Manual for Evidence Synthesis-JBI Global Wiki) and PRISMA_ScR (Tricco et al., Ann Intern Med. 2018; 169(7):467-473). A systematic search will be conducted across the following databases: PubMed, Cochrane, Embase, Ebsco, Medline, and Google scholar. Two independent reviewers will screen titles and abstracts, then review the full texts of articles. Data will be extracted and presented in line with the review questions.</p><p><strong>Strengths and limitations of this study: </strong>The study will use a structured approach, as guided by Arksey and O'Malley and JBI methodology. Studies not written in English, Danish, German, Swedish, and Norwegian will be translated using available software. This review will not include a formal assessment of the study quality or meta-analysis, as it is a scoping review.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e14591"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11848231/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143481992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypotension after anesthesia induction in patients taking tricyclic antidepressants-A case series. 三环类抗抑郁药麻醉诱导后低血压的临床观察。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.70001
Mads Lodsgaard, Birgitte Bech Melchiors, Mogens Krøigaard, Lene Heise Garvey

Background: Hypotension is commonly observed after induction of anesthesia. Risk factors for intraoperative hypotension include higher ASA class, older age, propofol use, combined general/regional anesthesia, emergency surgery, and use of antihypertensives. Patients who are treated with tricyclic antidepressants (TCAs) may develop severe hypotension in connection with surgery and anesthesia, not responding to vasopressors such as phenylephrine and ephedrine, and use of adrenaline or noradrenaline are necessary to restore the blood pressure. Anaphylaxis may be suspected due to the rapid onset and resistance to usual treatments leading to referral for allergy investigation. The aim of this paper was to identify and describe the clinical characteristics of patients referred to the Danish Anesthesia Allergy Center (DAAC) with perioperative hypotension, without elevation in tryptase, and with negative allergy investigations, who were on regular treatment with TCAs. The pharmacological mechanism behind this phenomenon will also be explored.

Methods: Patients were identified from the DAAC database. Patients with hypotension (systolic blood pressure <75 mmHg) as the only symptom and negative allergy investigations and patients on antidepressants were included. The study period was 2011-2019.

Results: Ten patients were identified. Hypotension occurred after anesthesia induction, the median time from induction to the onset of hypotension was 7.5 min. Eight needed adrenaline or noradrenaline to restore blood pressure. No allergen was identified on detailed investigation and serum tryptase was not significantly elevated.

Conclusion: Monosymptomatic perioperative hypotension without a significant increase in serum tryptase can be caused by TCAs and this is an important differential diagnosis to anaphylaxis. In patients on regular treatment with TCA perioperative hypotension responds well to noradrenaline or adrenaline but less well to vasopressors such as phenylephrine and ephedrine used perioperatively.

背景:在麻醉诱导后经常观察到低血压。术中低血压的危险因素包括ASA等级较高、年龄较大、使用异丙酚、全身/区域联合麻醉、急诊手术和使用抗高血压药物。接受三环抗抑郁药(TCAs)治疗的患者在手术和麻醉时可能出现严重的低血压,对苯肾上腺素和麻黄素等血管加压药物无反应,需要使用肾上腺素或去甲肾上腺素来恢复血压。由于快速发病和对常规治疗的抵抗,可能怀疑过敏反应,导致转诊进行过敏调查。本文的目的是识别和描述丹麦麻醉过敏中心(DAAC)患者的临床特征,这些患者围手术期低血压,没有胰酶升高,过敏调查阴性,接受TCAs常规治疗。这一现象背后的药理学机制也将被探讨。方法:从DAAC数据库中筛选患者。低血压患者(收缩压)结果:确定10例患者。麻醉诱导后出现低血压,诱导至低血压发生的中位时间为7.5 min。8人需要肾上腺素或去甲肾上腺素来恢复血压。详细调查未发现过敏原,血清胰蛋白酶未明显升高。结论:TCAs可引起围手术期无明显胰酶升高的单症状性低血压,是鉴别过敏反应的重要指标。常规TCA治疗的围手术期低血压患者对去甲肾上腺素或肾上腺素反应良好,但对围手术期使用的血管加压剂如苯肾上腺素和麻黄碱反应较差。
{"title":"Hypotension after anesthesia induction in patients taking tricyclic antidepressants-A case series.","authors":"Mads Lodsgaard, Birgitte Bech Melchiors, Mogens Krøigaard, Lene Heise Garvey","doi":"10.1111/aas.70001","DOIUrl":"10.1111/aas.70001","url":null,"abstract":"<p><strong>Background: </strong>Hypotension is commonly observed after induction of anesthesia. Risk factors for intraoperative hypotension include higher ASA class, older age, propofol use, combined general/regional anesthesia, emergency surgery, and use of antihypertensives. Patients who are treated with tricyclic antidepressants (TCAs) may develop severe hypotension in connection with surgery and anesthesia, not responding to vasopressors such as phenylephrine and ephedrine, and use of adrenaline or noradrenaline are necessary to restore the blood pressure. Anaphylaxis may be suspected due to the rapid onset and resistance to usual treatments leading to referral for allergy investigation. The aim of this paper was to identify and describe the clinical characteristics of patients referred to the Danish Anesthesia Allergy Center (DAAC) with perioperative hypotension, without elevation in tryptase, and with negative allergy investigations, who were on regular treatment with TCAs. The pharmacological mechanism behind this phenomenon will also be explored.</p><p><strong>Methods: </strong>Patients were identified from the DAAC database. Patients with hypotension (systolic blood pressure <75 mmHg) as the only symptom and negative allergy investigations and patients on antidepressants were included. The study period was 2011-2019.</p><p><strong>Results: </strong>Ten patients were identified. Hypotension occurred after anesthesia induction, the median time from induction to the onset of hypotension was 7.5 min. Eight needed adrenaline or noradrenaline to restore blood pressure. No allergen was identified on detailed investigation and serum tryptase was not significantly elevated.</p><p><strong>Conclusion: </strong>Monosymptomatic perioperative hypotension without a significant increase in serum tryptase can be caused by TCAs and this is an important differential diagnosis to anaphylaxis. In patients on regular treatment with TCA perioperative hypotension responds well to noradrenaline or adrenaline but less well to vasopressors such as phenylephrine and ephedrine used perioperatively.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e70001"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11830959/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143432165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraoperative opioid administrations, rescue doses in the post-anaesthesia care unit and clinician-perceived factors for dose adjustments in adults: A Danish nationwide survey. 术中阿片类药物给药,麻醉后护理单位的抢救剂量和成人剂量调整的临床感知因素:丹麦全国调查。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.70000
Trang Xuan Minh Tran, Mik Wetterslev, Anders Kehlet Nørskov, Christian Sylvest Meyhoff, Markus Harboe Olsen, Theis Skovsgaard Itenov, Ole Mathiesen, Anders Peder Højer Karlsen

Background: The impact of demographic- and surgical factors on individual perioperative opioid requirements is not fully understood. Anaesthesia personnel adjust opioid administrations based on their own clinical experience, expert opinions and local guidelines. This survey aimed to assess the current practice of anaesthesia personnel regarding intraoperative opioid treatment for postoperative analgesia and rescue opioid dosing strategies in the post-anaesthesia care unit in Denmark.

Methods: We conducted a cross-sectional online survey with 37 questions addressing pain management and opioid-dosing strategies. Local site investigators from 46 of 47 public Danish anaesthesia departments distributed the survey. Data collection took place from 5 February to 30 April 2024.

Results: Of the 4187 survey participants, 2025 (48%) answered. Intra- and postoperative opioid doses were adjusted based on chronic pain, age, preoperative opioid use, body weight and type of surgery. Between 84% and 89% of respondents adhered to and had perioperative pain management guidelines available. Respondents preferred intraoperative fentanyl (44%) and morphine (36%) to prevent postoperative pain. Median intraoperative intravenous morphine equivalents ranged from 0.12 to 0.38 mg/kg in clinical scenarios. In these cases, the following variables were assembled in different combinations to assess their impact on dosing: age (30 vs. 65 years), sex (female vs. male), ASA score (1 vs. 3) and type of surgery (anterior cruciate ligament vs. laparoscopic cholecystectomy surgery). Respondents preferred intravenous morphine and fentanyl for moderate and severe postoperative pain, respectively. Median postoperative rescue doses were 0.06-0.12 mg/kg in clinical scenarios based on shifting combinations of the variables: age (30 vs. 65 years), ASA score (1 vs. 3) and degree of expected pain (moderate vs. severe).

Conclusion: Respondents preferred fentanyl and morphine for postoperative pain control with considerable variation in choice of opioid and morphine equivalent dose. Respondents expressed that guidelines were highly available and strongly adhered to. Opioid dosing was predominantly guided by chronic pain, age, preoperative opioid use, body weight and type of surgery.

背景:人口统计学和外科因素对个体围手术期阿片类药物需求的影响尚不完全清楚。麻醉人员根据自己的临床经验、专家意见和当地指南调整阿片类药物给药。本调查旨在评估目前丹麦麻醉人员对术中阿片类药物治疗术后镇痛的做法和麻醉后护理单位的阿片类药物剂量策略。方法:我们进行了一项横断面在线调查,共有37个问题,涉及疼痛管理和阿片类药物给药策略。来自47个丹麦公共麻醉部门中的46个的当地现场调查员分发了调查问卷。数据收集于2024年2月5日至4月30日进行。结果:在4187名调查对象中,有2025人(48%)回答了问题。根据慢性疼痛、年龄、术前阿片类药物使用、体重和手术类型调整手术内和术后阿片类药物剂量。84%至89%的应答者遵守并拥有围手术期疼痛管理指南。受访者更倾向于术中芬太尼(44%)和吗啡(36%)来预防术后疼痛。在临床情况下,术中静脉吗啡当量的中位数范围为0.12至0.38 mg/kg。在这些病例中,以下变量以不同的组合进行组合,以评估它们对剂量的影响:年龄(30岁vs 65岁)、性别(女性vs男性)、ASA评分(1 vs 3)和手术类型(前十字韧带vs腹腔镜胆囊切除术)。受访者分别倾向于静脉注射吗啡和芬太尼治疗中度和重度术后疼痛。根据年龄(30岁vs. 65岁)、ASA评分(1分vs. 3分)和预期疼痛程度(中度vs.重度)等变量的变化组合,临床情况下的术后抢救中位剂量为0.06-0.12 mg/kg。结论:受访者在阿片类药物和吗啡等效剂量的选择上差异较大,更倾向于芬太尼和吗啡用于术后疼痛控制。答复者表示,指导方针很容易获得并得到严格遵守。阿片类药物的剂量主要受慢性疼痛、年龄、术前阿片类药物使用、体重和手术类型的影响。
{"title":"Intraoperative opioid administrations, rescue doses in the post-anaesthesia care unit and clinician-perceived factors for dose adjustments in adults: A Danish nationwide survey.","authors":"Trang Xuan Minh Tran, Mik Wetterslev, Anders Kehlet Nørskov, Christian Sylvest Meyhoff, Markus Harboe Olsen, Theis Skovsgaard Itenov, Ole Mathiesen, Anders Peder Højer Karlsen","doi":"10.1111/aas.70000","DOIUrl":"10.1111/aas.70000","url":null,"abstract":"<p><strong>Background: </strong>The impact of demographic- and surgical factors on individual perioperative opioid requirements is not fully understood. Anaesthesia personnel adjust opioid administrations based on their own clinical experience, expert opinions and local guidelines. This survey aimed to assess the current practice of anaesthesia personnel regarding intraoperative opioid treatment for postoperative analgesia and rescue opioid dosing strategies in the post-anaesthesia care unit in Denmark.</p><p><strong>Methods: </strong>We conducted a cross-sectional online survey with 37 questions addressing pain management and opioid-dosing strategies. Local site investigators from 46 of 47 public Danish anaesthesia departments distributed the survey. Data collection took place from 5 February to 30 April 2024.</p><p><strong>Results: </strong>Of the 4187 survey participants, 2025 (48%) answered. Intra- and postoperative opioid doses were adjusted based on chronic pain, age, preoperative opioid use, body weight and type of surgery. Between 84% and 89% of respondents adhered to and had perioperative pain management guidelines available. Respondents preferred intraoperative fentanyl (44%) and morphine (36%) to prevent postoperative pain. Median intraoperative intravenous morphine equivalents ranged from 0.12 to 0.38 mg/kg in clinical scenarios. In these cases, the following variables were assembled in different combinations to assess their impact on dosing: age (30 vs. 65 years), sex (female vs. male), ASA score (1 vs. 3) and type of surgery (anterior cruciate ligament vs. laparoscopic cholecystectomy surgery). Respondents preferred intravenous morphine and fentanyl for moderate and severe postoperative pain, respectively. Median postoperative rescue doses were 0.06-0.12 mg/kg in clinical scenarios based on shifting combinations of the variables: age (30 vs. 65 years), ASA score (1 vs. 3) and degree of expected pain (moderate vs. severe).</p><p><strong>Conclusion: </strong>Respondents preferred fentanyl and morphine for postoperative pain control with considerable variation in choice of opioid and morphine equivalent dose. Respondents expressed that guidelines were highly available and strongly adhered to. Opioid dosing was predominantly guided by chronic pain, age, preoperative opioid use, body weight and type of surgery.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e70000"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11839308/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143456553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring management reasoning when discharging high-risk postoperative patients from the post-anaesthesia care unit. 探讨高危术后患者从麻醉后护理病房出院时的管理推理。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.14590
Lea Baunegaard Hvidberg, Hejdi Gamst-Jensen, Karlen Bader-Larsen, Nicolai Bang Foss, Eske Kvanner Aasvang, Martin Grønnebæk Tolsgaard

Introduction: Decision-support tools for detecting physiological deterioration are widely used in clinical medicine but have been criticised for fostering a task-oriented culture and reducing the emphasis on clinical reasoning. Little is understood about what influences clinical decisions aided by decision-support tools, including professional standards, policies, and contextual factors. Therefore, we explored management reasoning employed by anaesthesiologists and PACU nurses in the post-anaesthesia care unit during the discharge of high-risk postoperative patients.

Methods: A qualitative constructivist study, conducting 18 semi-structured with 6 anaesthesiologists and 12 nurses across three Danish teaching hospitals. We analysed data through thematic analysis, utilising Michael Lipsky's theory of "street-level bureaucracy" in combination with David A. Cook's Management Reasoning Framework as a sensitising concept.

Results: Standards are frequently ambiguous, requiring interpretation and prioritisation. This allows for professional discretion by circumventing established policies, reducing task-oriented culture and enhancing the clinical reasoning processes. However, discretion in management reasoning depends on whether the clinician is inclined to uphold or adjust policies to maintain professional standards, influencing discharge decisions.

Conclusion: While decision-support tools offer cognitive aid and help standardise patient trajectories, they also limit professional discretion in management reasoning and can potentially compromise care and treatment. This highlights the need for a balanced approach that considers both the benefits and limitations of these tools in clinical decision-making.

用于检测生理恶化的决策支持工具在临床医学中广泛使用,但因培养任务导向的文化和减少对临床推理的重视而受到批评。在决策支持工具(包括专业标准、政策和环境因素)的帮助下,对临床决策的影响知之甚少。因此,我们探讨麻醉医师和PACU护士在术后高危患者出院时麻醉后护理单元的管理推理。方法:采用质性建构主义研究方法,对丹麦三家教学医院的6名麻醉师和12名护士进行了18例半结构化研究。我们通过主题分析来分析数据,利用迈克尔·利普斯基的“街头官僚主义”理论,结合大卫·a·库克的管理推理框架作为一个敏感概念。结果:标准经常是模糊的,需要解释和优先级。这允许专业自由裁量权通过规避既定政策,减少以任务为导向的文化和加强临床推理过程。然而,管理推理的自由裁量权取决于临床医生是否倾向于维护或调整政策以保持专业标准,从而影响出院决定。结论:虽然决策支持工具提供了认知辅助并有助于规范患者轨迹,但它们也限制了管理推理的专业判断力,并可能损害护理和治疗。这突出了在临床决策中需要考虑到这些工具的优点和局限性的平衡方法。
{"title":"Exploring management reasoning when discharging high-risk postoperative patients from the post-anaesthesia care unit.","authors":"Lea Baunegaard Hvidberg, Hejdi Gamst-Jensen, Karlen Bader-Larsen, Nicolai Bang Foss, Eske Kvanner Aasvang, Martin Grønnebæk Tolsgaard","doi":"10.1111/aas.14590","DOIUrl":"10.1111/aas.14590","url":null,"abstract":"<p><strong>Introduction: </strong>Decision-support tools for detecting physiological deterioration are widely used in clinical medicine but have been criticised for fostering a task-oriented culture and reducing the emphasis on clinical reasoning. Little is understood about what influences clinical decisions aided by decision-support tools, including professional standards, policies, and contextual factors. Therefore, we explored management reasoning employed by anaesthesiologists and PACU nurses in the post-anaesthesia care unit during the discharge of high-risk postoperative patients.</p><p><strong>Methods: </strong>A qualitative constructivist study, conducting 18 semi-structured with 6 anaesthesiologists and 12 nurses across three Danish teaching hospitals. We analysed data through thematic analysis, utilising Michael Lipsky's theory of \"street-level bureaucracy\" in combination with David A. Cook's Management Reasoning Framework as a sensitising concept.</p><p><strong>Results: </strong>Standards are frequently ambiguous, requiring interpretation and prioritisation. This allows for professional discretion by circumventing established policies, reducing task-oriented culture and enhancing the clinical reasoning processes. However, discretion in management reasoning depends on whether the clinician is inclined to uphold or adjust policies to maintain professional standards, influencing discharge decisions.</p><p><strong>Conclusion: </strong>While decision-support tools offer cognitive aid and help standardise patient trajectories, they also limit professional discretion in management reasoning and can potentially compromise care and treatment. This highlights the need for a balanced approach that considers both the benefits and limitations of these tools in clinical decision-making.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e14590"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143187634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A descriptive, retrospective single-centre study of air-leak syndrome in intensive care unit patients with COVID-19. COVID-19重症监护病房患者漏气综合征的描述性、回顾性单中心研究
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.14582
Alice Löwing Jensen, Jacob Litorell, Jonathan Grip, Martin Dahlberg, Eva Joelsson-Alm, Sandra Jonmarker
<p><strong>Background: </strong>Acute respiratory failure is the predominant presentation of intensive care unit (ICU) patients with COVID-19, and lung protective strategies are recommended to mitigate additional respiratory complications such as air-leak syndrome. The aim of this study is to investigate the prevalence, type, and timing of air-leak syndrome with regards to associated factors and patient outcome in patients with COVID-19 in ICUs at a large Swedish emergency hospital.</p><p><strong>Methods: </strong>This retrospective study included all adult patients admitted to an ICU for COVID-19-related respiratory failure at Södersjukhuset between March 6, 2020, and June 6, 2021. Primary outcomes were proportion of patients diagnosed with air-leak syndrome and its different types of manifestations, and timing of diagnoses in relation to ICU admission and initiation of invasive ventilation. Secondary outcomes included the highest level of respiratory support prior to the diagnosis of air-leak syndrome, patient characteristics and treatment variables associated with air-leak syndrome, and 90-day mortality for patients with air-leak syndrome compared to those without.</p><p><strong>Results: </strong>Out of a total of 669 patients, 81 (12%) were diagnosed with air-leak syndrome. Air-leak syndrome manifested as pneumomediastinum (PMD) (n = 58, 72%), pneumothorax (PTX) (n = 43, 53%), subcutaneous emphysema (SCE) (n = 28, 35%) and pneumatocele (PC) (n = 4, 4.9%). Air-leak syndrome was diagnosed at a median of 14 days (IQR 6-22) after ICU admission and 12 days (IQR 6-19) following the initiation of invasive ventilation. The highest respiratory support prior to diagnosis was invasive ventilation (IV) in 64 patients (79%), non-invasive ventilation in two patients (2.5%), and low- or high-flow oxygen in 15 patients (19%). Multiple logistic regression showed that pulmonary disease at baseline (OR 1.87, 95% CI 1.07-3.25), a lower body mass index (OR 0.95, 95% CI 0.9-0.99), admission later compared with earlier in the pandemic (OR 3.89, 95% CI 2.14-7.08), and IV (OR 3.92, 95% CI 2.07-7.44) were associated with an increased risk of air-leak syndrome. Compared with patients not diagnosed with air-leak syndrome, patients with air-leaks had a higher mortality at 90 days after ICU admission, 46% versus 26% (p <.001). However, the mortality rate differed with different air-leak manifestations, 47% for PMD, 47% for PTX, 50% for the combination of both PMD and PTX and 0% in patients with only SCE and/or PC, respectively.</p><p><strong>Conclusion: </strong>In 669 ICU patients with COVID-19, 12% had one or more manifestations of air-leak syndrome. Notably, PMD, rather than PTX, was the most common manifestation, suggesting a potentially distinctive feature of COVID-19-related air-leak syndrome. Further research is needed to determine whether COVID-19 involves different pathophysiological or iatrogenic mechanisms compared with other critical respiratory conditions.</p
背景:急性呼吸衰竭是COVID-19重症监护病房(ICU)患者的主要表现,建议采取肺保护策略来减轻额外的呼吸并发症,如漏气综合征。本研究的目的是调查瑞典一家大型急救医院重症监护室COVID-19患者中漏气综合征的患病率、类型和时间与相关因素和患者预后的关系。方法:本回顾性研究纳入了2020年3月6日至2021年6月6日期间在Södersjukhuset因covid -19相关呼吸衰竭入住ICU的所有成年患者。主要观察指标为漏气综合征患者的比例及其不同类型的表现,以及诊断时间与ICU住院和开始有创通气的关系。次要结局包括漏气综合征诊断前的最高呼吸支持水平、与漏气综合征相关的患者特征和治疗变量,以及漏气综合征患者与无漏气综合征患者相比的90天死亡率。结果:669例患者中,81例(12%)被诊断为漏气综合征。漏气综合征表现为纵隔气肿(PMD) (n = 58, 72%)、气胸(n = 43, 53%)、皮下肺气肿(SCE) (n = 28, 35%)、气腹膨出(PC) (n = 4, 4.9%)。漏气综合征的诊断中位时间为ICU入院后14天(IQR 6-22),开始有创通气后12天(IQR 6-19)。诊断前最高的呼吸支持是有创通气(IV) 64例(79%),无创通气2例(2.5%),低流量或高流量吸氧15例(19%)。多元logistic回归显示,基线时肺部疾病(OR 1.87, 95% CI 1.07-3.25)、较低的体重指数(OR 0.95, 95% CI 0.99 -0.99)、入院时间较大流行早期晚(OR 3.89, 95% CI 2.14-7.08)和IV期(OR 3.92, 95% CI 2.07-7.44)与漏气综合征的风险增加相关。与未诊断为漏气综合征的患者相比,漏气患者在ICU入院后90天的死亡率更高,分别为46%和26% (p结论:在669例COVID-19 ICU患者中,12%的患者有一种或多种漏气综合征的表现。值得注意的是,PMD而不是PTX是最常见的表现,这表明与covid -19相关的漏气综合征可能具有独特的特征。与其他严重呼吸系统疾病相比,COVID-19是否涉及不同的病理生理或医源性机制,需要进一步研究。临床试验注册:Clinicaltrials.gov,识别号:NCT05877443。编者评论:这项关于通气COVID病例软组织漏气的单中心队列研究提出了相关因素和临床表现的发现,包括不同的COVID-19时期和治疗方法。
{"title":"A descriptive, retrospective single-centre study of air-leak syndrome in intensive care unit patients with COVID-19.","authors":"Alice Löwing Jensen, Jacob Litorell, Jonathan Grip, Martin Dahlberg, Eva Joelsson-Alm, Sandra Jonmarker","doi":"10.1111/aas.14582","DOIUrl":"10.1111/aas.14582","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Acute respiratory failure is the predominant presentation of intensive care unit (ICU) patients with COVID-19, and lung protective strategies are recommended to mitigate additional respiratory complications such as air-leak syndrome. The aim of this study is to investigate the prevalence, type, and timing of air-leak syndrome with regards to associated factors and patient outcome in patients with COVID-19 in ICUs at a large Swedish emergency hospital.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This retrospective study included all adult patients admitted to an ICU for COVID-19-related respiratory failure at Södersjukhuset between March 6, 2020, and June 6, 2021. Primary outcomes were proportion of patients diagnosed with air-leak syndrome and its different types of manifestations, and timing of diagnoses in relation to ICU admission and initiation of invasive ventilation. Secondary outcomes included the highest level of respiratory support prior to the diagnosis of air-leak syndrome, patient characteristics and treatment variables associated with air-leak syndrome, and 90-day mortality for patients with air-leak syndrome compared to those without.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Out of a total of 669 patients, 81 (12%) were diagnosed with air-leak syndrome. Air-leak syndrome manifested as pneumomediastinum (PMD) (n = 58, 72%), pneumothorax (PTX) (n = 43, 53%), subcutaneous emphysema (SCE) (n = 28, 35%) and pneumatocele (PC) (n = 4, 4.9%). Air-leak syndrome was diagnosed at a median of 14 days (IQR 6-22) after ICU admission and 12 days (IQR 6-19) following the initiation of invasive ventilation. The highest respiratory support prior to diagnosis was invasive ventilation (IV) in 64 patients (79%), non-invasive ventilation in two patients (2.5%), and low- or high-flow oxygen in 15 patients (19%). Multiple logistic regression showed that pulmonary disease at baseline (OR 1.87, 95% CI 1.07-3.25), a lower body mass index (OR 0.95, 95% CI 0.9-0.99), admission later compared with earlier in the pandemic (OR 3.89, 95% CI 2.14-7.08), and IV (OR 3.92, 95% CI 2.07-7.44) were associated with an increased risk of air-leak syndrome. Compared with patients not diagnosed with air-leak syndrome, patients with air-leaks had a higher mortality at 90 days after ICU admission, 46% versus 26% (p &lt;.001). However, the mortality rate differed with different air-leak manifestations, 47% for PMD, 47% for PTX, 50% for the combination of both PMD and PTX and 0% in patients with only SCE and/or PC, respectively.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;In 669 ICU patients with COVID-19, 12% had one or more manifestations of air-leak syndrome. Notably, PMD, rather than PTX, was the most common manifestation, suggesting a potentially distinctive feature of COVID-19-related air-leak syndrome. Further research is needed to determine whether COVID-19 involves different pathophysiological or iatrogenic mechanisms compared with other critical respiratory conditions.&lt;/p","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e14582"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11816560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143397544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What matters to mothers: A qualitative exploration of pain and recovery after cesarean section. 对母亲来说重要的是:剖宫产术后疼痛和恢复的定性探索。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.14579
Patricia Duch, Kim Ekelund, Helene Korvenius Nedergaard

Background: Fast recovery after cesarean section is vital since the mother not only has to take care of herself but also the newborn. Recovery scores are useful tools to measure and compare recovery; however, standardized questionnaires may miss in-depth patient experiences. What is important to women in the postoperative period after cesarean section can vary in different populations, making it crucial to understand the specific needs of one's own population. This study aims to explore what matters most to Danish mothers during the early phase of recovery following elective cesarean section.

Methods: Qualitative design: Adult, Danish-speaking women undergoing elective cesarean section under spinal anesthesia were included in three Danish hospitals. Semi-structured interviews focusing on women's experiences of recovery, pain, and mobilization both in hospital and after discharge were conducted for 4-7 days following their cesarean section. Baseline characteristics and maternal outcomes were collected from patient files. The interviews were recorded, transcribed verbatim, and analyzed using manifest content analysis.

Results: In total, 25 women were interviewed a median of 6 days post cesarean section (IQR 5-8). Three themes emerged: "Experience of being a cesarean section patient," "I'm doing good - and better than expected," and "Challenges when going home." The cesarean section itself was described as a disturbing experience. The initial days post-cesarean section were described as very painful, but hereafter, many patients expressed surprise at their rapid recovery. None used opioids after discharge. Post-discharge, having a partner's support, especially with other children to care for, was helpful, and moving from lying to sitting position and getting out of bed were noted as particularly painful. Many women requested more information and specific rehabilitation programs.

Conclusions: In this qualitative study of Danish women 4-7 days after elective cesarean sections, the women described the initial days as very painful but felt that they recovered rather quickly thereafter. The study indicated a need for enhanced communication, especially regarding the experience of surgery, pain after cesarean section, and physical rehabilitation plans.

Editorial comment: In this qualitative, explorative study, participants were interviewed by telephone 4-7 days following their elective cesarean section. The focus was the women's experience of recovery, pain, and mobilization, both in hospital and when going home. The findings identified a need for more information about the perioperative course, as most participants were surprised and unprepared both for the pain from other areas than the scar and for the surgery experience being unpleasant, and many requested physical rehabilitation plans.

背景:剖宫产术后快速恢复至关重要,因为母亲不仅要照顾好自己,还要照顾好新生儿。恢复分数是衡量和比较恢复的有用工具;然而,标准化问卷可能会错过深入的患者体验。剖宫产术后对妇女的重要性在不同人群中可能有所不同,因此了解本国人群的具体需求至关重要。本研究旨在探讨丹麦母亲在择期剖宫产术后恢复的早期阶段最重要的事情。方法:定性设计:在丹麦三家医院接受脊髓麻醉下剖宫产术的成年丹麦语妇女。在剖宫产手术后的4-7天内,对妇女进行了半结构化访谈,重点关注她们在医院和出院后的康复、疼痛和活动经历。从患者档案中收集基线特征和产妇结局。访谈被记录下来,逐字转录,并使用清单内容分析进行分析。结果:共访谈25名妇女,中位时间为剖宫产术后6天(IQR 5-8)。三个主题出现了:“剖宫产病人的经历”,“我做得很好——比预期的要好”,以及“回家时的挑战”。剖宫产本身被描述为一种令人不安的经历。剖宫产术后的最初几天被描述为非常痛苦,但此后,许多患者对他们的快速恢复感到惊讶。出院后均未使用阿片类药物。出院后,有伴侣的支持,特别是有其他孩子需要照顾,是有帮助的,从躺着的姿势到坐着的姿势以及下床的姿势都被认为是特别痛苦的。许多妇女要求更多的信息和具体的康复方案。结论:在这项对丹麦妇女择期剖宫产后4-7天的定性研究中,妇女描述了最初的几天非常痛苦,但此后她们觉得自己恢复得相当快。研究表明需要加强沟通,特别是关于手术经验、剖宫产后疼痛和身体康复计划。编辑评论:在这项定性的探索性研究中,参与者在择期剖宫产术后4-7天接受电话采访。重点是妇女在医院和回家时的康复、疼痛和活动经历。研究结果表明,需要更多关于围手术期的信息,因为大多数参与者对疤痕以外其他部位的疼痛和手术经历的不愉快感到惊讶和措手不及,许多人要求物理康复计划。
{"title":"What matters to mothers: A qualitative exploration of pain and recovery after cesarean section.","authors":"Patricia Duch, Kim Ekelund, Helene Korvenius Nedergaard","doi":"10.1111/aas.14579","DOIUrl":"10.1111/aas.14579","url":null,"abstract":"<p><strong>Background: </strong>Fast recovery after cesarean section is vital since the mother not only has to take care of herself but also the newborn. Recovery scores are useful tools to measure and compare recovery; however, standardized questionnaires may miss in-depth patient experiences. What is important to women in the postoperative period after cesarean section can vary in different populations, making it crucial to understand the specific needs of one's own population. This study aims to explore what matters most to Danish mothers during the early phase of recovery following elective cesarean section.</p><p><strong>Methods: </strong>Qualitative design: Adult, Danish-speaking women undergoing elective cesarean section under spinal anesthesia were included in three Danish hospitals. Semi-structured interviews focusing on women's experiences of recovery, pain, and mobilization both in hospital and after discharge were conducted for 4-7 days following their cesarean section. Baseline characteristics and maternal outcomes were collected from patient files. The interviews were recorded, transcribed verbatim, and analyzed using manifest content analysis.</p><p><strong>Results: </strong>In total, 25 women were interviewed a median of 6 days post cesarean section (IQR 5-8). Three themes emerged: \"Experience of being a cesarean section patient,\" \"I'm doing good - and better than expected,\" and \"Challenges when going home.\" The cesarean section itself was described as a disturbing experience. The initial days post-cesarean section were described as very painful, but hereafter, many patients expressed surprise at their rapid recovery. None used opioids after discharge. Post-discharge, having a partner's support, especially with other children to care for, was helpful, and moving from lying to sitting position and getting out of bed were noted as particularly painful. Many women requested more information and specific rehabilitation programs.</p><p><strong>Conclusions: </strong>In this qualitative study of Danish women 4-7 days after elective cesarean sections, the women described the initial days as very painful but felt that they recovered rather quickly thereafter. The study indicated a need for enhanced communication, especially regarding the experience of surgery, pain after cesarean section, and physical rehabilitation plans.</p><p><strong>Editorial comment: </strong>In this qualitative, explorative study, participants were interviewed by telephone 4-7 days following their elective cesarean section. The focus was the women's experience of recovery, pain, and mobilization, both in hospital and when going home. The findings identified a need for more information about the perioperative course, as most participants were surprised and unprepared both for the pain from other areas than the scar and for the surgery experience being unpleasant, and many requested physical rehabilitation plans.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e14579"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11757011/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143031807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adverse event signal analysis of remimazolam using the FDA adverse event reporting system database. 利用FDA不良事件报告系统数据库分析雷马唑仑的不良事件信号。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.14588
Hongtao Liu, Zhaoyu Li, Su Yan, Shaopeng Ming

Background: Remimazolam, a novel ultra-short-acting benzodiazepine, has gained popularity in various anesthetic applications due to its pharmacokinetic advantages. However, as its use increases, safety concerns also rise, necessitating thorough examination. Additionally, the limited reports on its side effects require a broader investigation to better understand the drug's safety profile.

Methods: This observational study systematically investigated adverse drug events (ADEs) associated with remimazolam using the FAERS database from Q1 2020 to Q4 2023. The primary objective was to assess potential safety signals and provide comprehensive information for clinical and regulatory purposes.

Results: A total of 67 cases and 161 ADEs were identified. The incidence of ADEs was higher in patients aged >45 years, particularly those >65 years. Intravenous general anaesthesia was the most common administration method. Notable ADE signals included serious events such as allergic reactions, respiratory and cardiac arrest, and vascular access occlusion.

Conclusion: Clinicians should be vigilant about potential allergic reactions to remimazolam, especially in older patients, and avoid off-label use until more data are available. Continuous monitoring of post-market surveillance data is essential for uncovering undetected ADEs and ensuring the safe use of remimazolam.

Editorial comment: This study analyzed adverse drug events (ADEs) associated with remimazolam using the FAERS database, identifying serious safety signals like allergic reactions, respiratory and cardiac arrests, and vascular access site occlusions, especially in older patients. The findings highlight the need for vigilant monitoring, cautious off-label use, and ongoing post-marketing surveillance.

背景:雷马唑仑是一种新型超短效苯二氮卓类药物,因其药代动力学优势在各种麻醉应用中广受欢迎。然而,随着其使用量的增加,人们对其安全性的担忧也随之增加,因此有必要对其进行彻底检查。此外,有关其副作用的报告有限,需要进行更广泛的调查,以更好地了解该药物的安全性:这项观察性研究利用 FAERS 数据库系统调查了 2020 年第一季度至 2023 年第四季度与雷马唑仑相关的药物不良事件 (ADE)。主要目的是评估潜在的安全信号,并为临床和监管提供全面的信息:结果:共发现 67 例 ADE 和 161 例 ADE。年龄大于 45 岁的患者 ADE 发生率较高,尤其是年龄大于 65 岁的患者。静脉全身麻醉是最常见的给药方法。值得注意的ADE信号包括过敏反应、呼吸和心跳骤停以及血管通路闭塞等严重事件:临床医生应对雷马唑仑的潜在过敏反应保持警惕,尤其是老年患者,并在获得更多数据之前避免标签外使用。持续监测上市后监测数据对于发现未发现的 ADEs 和确保安全使用雷马唑仑至关重要:这项研究利用 FAERS 数据库分析了与雷马唑仑相关的药物不良事件 (ADE),发现了过敏反应、呼吸和心跳骤停、血管通路部位闭塞等严重的安全信号,尤其是在老年患者中。这些发现强调了警惕性监测、谨慎标示外使用和上市后持续监控的必要性。
{"title":"Adverse event signal analysis of remimazolam using the FDA adverse event reporting system database.","authors":"Hongtao Liu, Zhaoyu Li, Su Yan, Shaopeng Ming","doi":"10.1111/aas.14588","DOIUrl":"10.1111/aas.14588","url":null,"abstract":"<p><strong>Background: </strong>Remimazolam, a novel ultra-short-acting benzodiazepine, has gained popularity in various anesthetic applications due to its pharmacokinetic advantages. However, as its use increases, safety concerns also rise, necessitating thorough examination. Additionally, the limited reports on its side effects require a broader investigation to better understand the drug's safety profile.</p><p><strong>Methods: </strong>This observational study systematically investigated adverse drug events (ADEs) associated with remimazolam using the FAERS database from Q1 2020 to Q4 2023. The primary objective was to assess potential safety signals and provide comprehensive information for clinical and regulatory purposes.</p><p><strong>Results: </strong>A total of 67 cases and 161 ADEs were identified. The incidence of ADEs was higher in patients aged >45 years, particularly those >65 years. Intravenous general anaesthesia was the most common administration method. Notable ADE signals included serious events such as allergic reactions, respiratory and cardiac arrest, and vascular access occlusion.</p><p><strong>Conclusion: </strong>Clinicians should be vigilant about potential allergic reactions to remimazolam, especially in older patients, and avoid off-label use until more data are available. Continuous monitoring of post-market surveillance data is essential for uncovering undetected ADEs and ensuring the safe use of remimazolam.</p><p><strong>Editorial comment: </strong>This study analyzed adverse drug events (ADEs) associated with remimazolam using the FAERS database, identifying serious safety signals like allergic reactions, respiratory and cardiac arrests, and vascular access site occlusions, especially in older patients. The findings highlight the need for vigilant monitoring, cautious off-label use, and ongoing post-marketing surveillance.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e14588"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143412684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fluid accumulation in adult ICU patients - A protocol for a scoping review. 成人ICU患者的积液——一项范围审查方案
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.14584
Clara Molin, Sine Wichmann, Martin Schønemann-Lund, Morten Hylander Møller, Morten Heiberg Bestle

Introduction: Fluid accumulation in critically ill patients is associated with adverse outcomes. However, there is a substantial variability in the terminology and definitions used to describe fluid accumulation. We aim to provide an overview of evidence describing fluid accumulation in critically ill adult patients admitted to the intensive care unit (ICU), including how it is defined, patient characteristics associated with fluid accumulation, ICU population, and outcomes assessed.

Methods: We will conduct a scoping review prepared according to the Preferred Reporting Items for Systematic and Meta-analysis extension for Scoping reviews (PRISMA-ScR). Pubmed, MEDLINE, EMBASE, and Cochrane Library will be searched systematically. All clinical studies reporting original data and investigating fluid accumulation, as defined by authors, in adult ICU patients will be included. We will assess the study design, the definition of fluid accumulation, ICU population, and the outcomes measured, categorised as patient-important or non-patient important, in the included studies. The results will be reported descriptively. The certainty of evidence will be assessed using a modified Grading of Recommendations Assessment, Development, and Evaluation (GRADE) on the research question level.

Discussion: This scoping review will provide an overview of definitions used for fluid accumulation, and describe ICU patient populations, patient characteristics, and outcomes assessed in ICU research.

危重病人的体液积聚与不良后果相关。然而,用于描述流体积聚的术语和定义存在很大差异。我们的目的是概述重症监护病房(ICU)重症成人患者液体积聚的证据,包括如何定义、与液体积聚相关的患者特征、ICU人群和评估的结果。方法:我们将根据系统和荟萃分析扩展范围评价的首选报告项目(PRISMA-ScR)进行范围评价。系统检索Pubmed, MEDLINE, EMBASE和Cochrane图书馆。所有临床研究报告原始数据和调查液体积聚,如作者所定义的,在成人ICU患者将被纳入。我们将在纳入的研究中评估研究设计、液体积聚的定义、ICU人群和测量的结果,并将其分类为患者重要或非患者重要。结果将以描述性的方式报告。证据的确定性将在研究问题水平上使用改良的建议评估、发展和评价分级(GRADE)来评估。讨论:这篇范围综述将概述液体积聚的定义,并描述ICU患者群体、患者特征和ICU研究评估的结果。
{"title":"Fluid accumulation in adult ICU patients - A protocol for a scoping review.","authors":"Clara Molin, Sine Wichmann, Martin Schønemann-Lund, Morten Hylander Møller, Morten Heiberg Bestle","doi":"10.1111/aas.14584","DOIUrl":"10.1111/aas.14584","url":null,"abstract":"<p><strong>Introduction: </strong>Fluid accumulation in critically ill patients is associated with adverse outcomes. However, there is a substantial variability in the terminology and definitions used to describe fluid accumulation. We aim to provide an overview of evidence describing fluid accumulation in critically ill adult patients admitted to the intensive care unit (ICU), including how it is defined, patient characteristics associated with fluid accumulation, ICU population, and outcomes assessed.</p><p><strong>Methods: </strong>We will conduct a scoping review prepared according to the Preferred Reporting Items for Systematic and Meta-analysis extension for Scoping reviews (PRISMA-ScR). Pubmed, MEDLINE, EMBASE, and Cochrane Library will be searched systematically. All clinical studies reporting original data and investigating fluid accumulation, as defined by authors, in adult ICU patients will be included. We will assess the study design, the definition of fluid accumulation, ICU population, and the outcomes measured, categorised as patient-important or non-patient important, in the included studies. The results will be reported descriptively. The certainty of evidence will be assessed using a modified Grading of Recommendations Assessment, Development, and Evaluation (GRADE) on the research question level.</p><p><strong>Discussion: </strong>This scoping review will provide an overview of definitions used for fluid accumulation, and describe ICU patient populations, patient characteristics, and outcomes assessed in ICU research.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e14584"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11757096/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143031803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-dose glucocorticoids in the treatment of postoperative pain after video-assisted thoracoscopic surgery-protocol for systematic review and meta-analysis. 大剂量糖皮质激素治疗电视胸腔镜手术后疼痛——系统回顾和荟萃分析方案
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.14577
Bertram Vorm, Anni Nørgaard Jeppesen, Lene Mølgaard Hansen, Mads Lumholdt, Thomas Lass Klitgaard, Allan Vestergaard Danielsen, Peter Juhl-Olsen, Phillip Sperling, Jannie Bisgaard

Background: Video-assisted thoracoscopic surgery (VATS) is widely used in lung cancer surgery, as this technique causes less pain and faster recovery than open thoracotomy. However, significant postoperative pain persists in a number of patients, often leading to increased opioid use and opioid-related adverse events in addition to prolonged admission times. Perioperatively administered glucocorticoids have been demonstrated effective in reducing pain after other types of surgeries, but the effect in VATS remains unclear.

Methods: This systematic review will assess the impact of glucocorticoids on postoperative pain in adult patients undergoing VATS. We will include randomised trials comparing higher doses of glucocorticoids to lower doses, placebo or no treatment. The review will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement and Cochrane methodology. The certainty of evidence will be assessed using the Grading of Recommendations Assessment, Development and Evaluation system. The primary outcome is standardised dynamic pain scores within 24 h. Secondary outcomes are opioid use, time to first mobilisation, length of hospital stay and numeric rating score >3 at any point within the first 24 h following surgery. Exploratory outcomes are opioid-related adverse effects and glucocorticoid-related adverse effects classified in major and minor events. Data will be meta-analysed with sensitivity and subgroup analyses and trial sequential analyses. Furthermore, we will assess the risk of reporting bias and heterogeneity.

Conclusion: This systematic review and meta-analysis will provide an overview of the current evidence of how glucocorticoids affect postoperative pain and recovery in adult patients undergoing VATS.

背景:视频胸腔镜手术(VATS)广泛应用于肺癌手术,因为该技术比开胸手术疼痛更小,恢复更快。然而,在许多患者中,明显的术后疼痛持续存在,除了延长住院时间外,还经常导致阿片类药物使用增加和阿片类药物相关不良事件。围手术期使用糖皮质激素已被证明能有效减轻其他类型手术后的疼痛,但其在VATS中的效果尚不清楚。方法:本系统综述将评估糖皮质激素对成年VATS患者术后疼痛的影响。我们将纳入比较高剂量糖皮质激素与低剂量、安慰剂或不治疗的随机试验。本综述将遵循系统评价和荟萃分析声明的首选报告项目和Cochrane方法学。证据的确定性将采用建议分级评估、发展和评估系统进行评估。主要结果是24小时内的标准化动态疼痛评分。次要结局是阿片类药物的使用、首次活动的时间、住院时间和手术后24小时内任何时间点的数字评分>.3。探索性结果是阿片类药物相关的不良反应和糖皮质激素相关的不良反应,分为主要和次要事件。数据将进行meta分析,包括敏感性分析、亚组分析和试验序列分析。此外,我们将评估报告偏倚和异质性的风险。结论:本系统综述和荟萃分析将概述当前关于糖皮质激素如何影响成年VATS患者术后疼痛和恢复的证据。
{"title":"High-dose glucocorticoids in the treatment of postoperative pain after video-assisted thoracoscopic surgery-protocol for systematic review and meta-analysis.","authors":"Bertram Vorm, Anni Nørgaard Jeppesen, Lene Mølgaard Hansen, Mads Lumholdt, Thomas Lass Klitgaard, Allan Vestergaard Danielsen, Peter Juhl-Olsen, Phillip Sperling, Jannie Bisgaard","doi":"10.1111/aas.14577","DOIUrl":"10.1111/aas.14577","url":null,"abstract":"<p><strong>Background: </strong>Video-assisted thoracoscopic surgery (VATS) is widely used in lung cancer surgery, as this technique causes less pain and faster recovery than open thoracotomy. However, significant postoperative pain persists in a number of patients, often leading to increased opioid use and opioid-related adverse events in addition to prolonged admission times. Perioperatively administered glucocorticoids have been demonstrated effective in reducing pain after other types of surgeries, but the effect in VATS remains unclear.</p><p><strong>Methods: </strong>This systematic review will assess the impact of glucocorticoids on postoperative pain in adult patients undergoing VATS. We will include randomised trials comparing higher doses of glucocorticoids to lower doses, placebo or no treatment. The review will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement and Cochrane methodology. The certainty of evidence will be assessed using the Grading of Recommendations Assessment, Development and Evaluation system. The primary outcome is standardised dynamic pain scores within 24 h. Secondary outcomes are opioid use, time to first mobilisation, length of hospital stay and numeric rating score >3 at any point within the first 24 h following surgery. Exploratory outcomes are opioid-related adverse effects and glucocorticoid-related adverse effects classified in major and minor events. Data will be meta-analysed with sensitivity and subgroup analyses and trial sequential analyses. Furthermore, we will assess the risk of reporting bias and heterogeneity.</p><p><strong>Conclusion: </strong>This systematic review and meta-analysis will provide an overview of the current evidence of how glucocorticoids affect postoperative pain and recovery in adult patients undergoing VATS.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e14577"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11757097/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143031805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical practice and outcomes in European pediatric cardiac anesthesia: A secondary analysis of the APRICOT and NECTARINE studies. 欧洲儿童心脏麻醉的临床实践和结果:对杏和油桃研究的二次分析。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.14585
Albert Gyllencreutz Castellheim, Walid Habre, Tom Giedsing Hansen

Background: Despite advancements in surgical techniques and perioperative care, pediatric cardiac patients remain at an increased risk of adverse events. The APRICOT (2017) study aimed to establish the incidence of severe critical events in children undergoing anesthesia in Europe, while the NECTARINE (2021) study aimed to assess anesthesia practices and outcomes in neonates and infants under 60 weeks postconceptual age. Our goal was to conduct a secondary analysis of the cardiac cohorts from these two studies to determine mortality rates and other outcomes after cardiac procedures at 30 and 90 days, identify factors influencing mortality, illustrate clinical practices, and assess the methodology of the two studies.

Methods: Sub-analysis of the data from APRICOT and NECTARINE. Data representativity was assessed through a systematic categorization process. European countries were divided into four income groups based on their gross national income per capita. Subsequently, the total number of patients across all four income groups was calculated for both the Apricot and Nectarine studies, and then the specific contribution of each income group to the total population of each study was determined.

Results: This analysis comprised 1016 cases (Apricot, n = 476 and Nectarine, n = 540). There was a considerable variability in clinical practice in Europe. The overall mortality rates were 0.84% (APRICOT) and 8.1% (NECTARINE). In both cohorts, substantial mortality was observed among low-age and low-weight infants. Stratifying the participating countries by income illustrated that the data originated from highest-income and upper-middle-income European countries and were not representative of low-income and middle-income countries.

Conclusions: In this secondary analysis of the APRICOT and NECTARINE studies, we found that fatal cases primarily occurred in low-age and low-weight neonates and infants.

Editorial comment: This secondary analysis of the APRICOT and NECTARINE studies focused on pediatric cardiac surgical cases. Outcomes differed according to weight and age of the children, where mortality risk was higher for very young and low-weight children.

背景:尽管手术技术和围手术期护理有所进步,但儿科心脏病患者不良事件的风险仍在增加。APRICOT(2017)研究旨在确定欧洲接受麻醉的儿童严重危重事件的发生率,而NECTARINE(2021)研究旨在评估新生儿和孕后60周以下婴儿的麻醉实践和结果。我们的目标是对这两项研究的心脏队列进行二次分析,以确定心脏手术后30天和90天的死亡率和其他结果,确定影响死亡率的因素,说明临床实践,并评估这两项研究的方法学。方法:对杏和油桃的资料进行亚分析。通过系统的分类过程评估数据的代表性。欧洲国家根据人均国民总收入分为四个收入组。随后,计算杏和油桃研究中所有四个收入群体的患者总数,然后确定每个收入群体对每个研究的总人口的具体贡献。结果:本分析共纳入1016例(杏,n = 476,油桃,n = 540)。在欧洲的临床实践中有相当大的差异。总死亡率分别为0.84%(杏)和8.1%(油桃)。在这两个队列中,在低年龄和低体重婴儿中观察到大量死亡率。按收入对参与国进行分层表明,数据来自收入最高和中上收入的欧洲国家,并不代表低收入和中等收入国家。结论:在对APRICOT和NECTARINE研究的二次分析中,我们发现致命病例主要发生在低年龄和低体重的新生儿和婴儿中。编辑评论:这是对APRICOT和NECTARINE研究的二次分析,重点是儿科心脏手术病例。结果因儿童的体重和年龄而异,非常年幼和体重过轻的儿童死亡风险更高。
{"title":"Clinical practice and outcomes in European pediatric cardiac anesthesia: A secondary analysis of the APRICOT and NECTARINE studies.","authors":"Albert Gyllencreutz Castellheim, Walid Habre, Tom Giedsing Hansen","doi":"10.1111/aas.14585","DOIUrl":"10.1111/aas.14585","url":null,"abstract":"<p><strong>Background: </strong>Despite advancements in surgical techniques and perioperative care, pediatric cardiac patients remain at an increased risk of adverse events. The APRICOT (2017) study aimed to establish the incidence of severe critical events in children undergoing anesthesia in Europe, while the NECTARINE (2021) study aimed to assess anesthesia practices and outcomes in neonates and infants under 60 weeks postconceptual age. Our goal was to conduct a secondary analysis of the cardiac cohorts from these two studies to determine mortality rates and other outcomes after cardiac procedures at 30 and 90 days, identify factors influencing mortality, illustrate clinical practices, and assess the methodology of the two studies.</p><p><strong>Methods: </strong>Sub-analysis of the data from APRICOT and NECTARINE. Data representativity was assessed through a systematic categorization process. European countries were divided into four income groups based on their gross national income per capita. Subsequently, the total number of patients across all four income groups was calculated for both the Apricot and Nectarine studies, and then the specific contribution of each income group to the total population of each study was determined.</p><p><strong>Results: </strong>This analysis comprised 1016 cases (Apricot, n = 476 and Nectarine, n = 540). There was a considerable variability in clinical practice in Europe. The overall mortality rates were 0.84% (APRICOT) and 8.1% (NECTARINE). In both cohorts, substantial mortality was observed among low-age and low-weight infants. Stratifying the participating countries by income illustrated that the data originated from highest-income and upper-middle-income European countries and were not representative of low-income and middle-income countries.</p><p><strong>Conclusions: </strong>In this secondary analysis of the APRICOT and NECTARINE studies, we found that fatal cases primarily occurred in low-age and low-weight neonates and infants.</p><p><strong>Editorial comment: </strong>This secondary analysis of the APRICOT and NECTARINE studies focused on pediatric cardiac surgical cases. Outcomes differed according to weight and age of the children, where mortality risk was higher for very young and low-weight children.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e14585"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11780212/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143062865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Anaesthesiologica Scandinavica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1